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 ADHD, ASD, and anxiety are three of the most common co-occurring disorders 
in children with FXS leading to increased social, academic, and behavioral difficulties (Bailey, 
Raspa, Olmsted, & Holiday, 2008). Early identification and treatment of these co-occurring 
mental health disorders is essential to promote optimal outcomes; therefore, the study of early 
precursors and underlying mechanisms of these disorders within a developmental framework is 
warranted. The current dissertation includes two sequential and related studies investigating 
impaired effortful control as a precursor and HPA axis dysfunction (measured through salivary 
cortisol) as an underlying mechanism to the emergence of ADHD, ASD, and anxiety in young 
boys with FXS. Results indicate that boys with FXS exhibit lower levels of effortful control and 
higher levels of cortisol compared to typically developing controls; however, no significant 
relationship between effortful control and cortisol was found. Additionally, significantly higher 
levels of ASD symptoms were found in the FXS group. Due to significant variability in 
individual ADHD, ASD, and anxiety trajectories across FXS and typically developing young 
boys, no specific trend in developmental trajectories was found. Impaired effortful control did not 
significantly relate to ADHD, ASD, or anxiety symptoms; however, increased cortisol levels 
were found to relate to increased anxiety symptoms. Future research is necessary to better 
understand the development of these disorders within FXS throughout childhood to assist with 
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Fragile X Syndrome (FXS) is the most common inherited cause of intellectual 
disability affecting as many as 1 in 2,500 males (Fernandez-Carvajal et al. 2009; 
Hagerman, 2008). An expanded number of CGG trinucleotide repeats at the FMR1 gene 
(Xq27.3) on the X chromosome causes FXS. The consequence of expanded CGG repeats 
is a reduction of the expression of the fragile X mental retardation protein (FMRP), 
leading to atypical brain development (Crawford, Acuna, & Sherman, 2001). The full 
mutation of fragile X occurs when the expansions of CGG reach 200 or more while the 
FX premutation occurs with 55-199 CGG repeats (Yu et al., 1991). Cognitive impairment 
is one of the core features of FXS as IQ scores typically fall in the moderate range of 
intellectual disabilities (IQ scores between 45 and 60; e.g. Loesch et al., 2002; Hall et al., 
2008; Hooper et al., 2008). Gender differences exist within the full mutation as females 
typically experience less severe impairment compared to males due to the second X 
chromosome available to produce the FMRP protein. Diagnoses can be made via pre- or 
post-natal genetic testing; however, in the absence of a family history, FXS is not 
typically diagnosed in boys until 37 months (Bailey, Raspa, Bishop, & Holiday, 2009). 
While intellectual disabilities are almost hallmark in fragile X syndrome, nearly 
80% of individuals with FXS have one or more co-occurring condition (Bailey, Raspa, 
Olmstead, and Holiday, 2008). Attention-deficit hyperactivity disorder (ADHD; 84%), 
autism spectrum disorder (ASD; 46%), and anxiety (70%) are three of the most 
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commonly identified comorbid conditions within FXS (Bailey, Raspa, Olmstead, and 
Holiday, 2008; Cordeiro, Ballinger, Hagerman, & Hessl, 2011). Individuals with FXS 
and other co-occurring conditions tend to have poorer outcomes including greater 
behavior problems, more restrictive school placements, lower levels of personal 
independence, reduced language skills, and poorer social skills (e.g. Faraone, Biederman, 
& Zimmerman, 2005; Handen, Janosky, & McAuliffe, 1997; Bailey et al., 2000; Hatton 
et al., 2002; Kau et al, 2004). Additionally, many individuals with FXS experience sub-
threshold symptoms of ADHD, ASD, and anxiety and experience some of these negative 
outcomes due to the symptom manifestations (Bailey et al., 2008).  For example, more 
than 80% of children with FXS have been treated for attention problems, 90% of children 
with FXS exhibit one or more symptoms of ASD, and 56-70% of children with FXS 
receive treatment for anxiety problems (Bailey et al., 2008; Clifford et al., 2007). Due to 
the greater negative outcomes associated with comorbidities in FXS as well as sub-
threshold symptom manifestations, there is a greater need for early identification and 
further research on the study of symptom severity to facilitate treatment efforts.  
In children without FXS, ADHD typically emerges before the age of 5 with an 
average diagnosis age of 7 (CDC, 2010) while ASD typically emerges between the ages 
of 2 and 3 years with an average diagnosis age of 4 (Lord et al., 2006; CDC, 2012). 
Anxiety disorders typically emerge during middle childhood before the age of 12 
(Beesbo, Knappe, & Pine, 2009). While children with FXS exhibit higher rates of these 
comorbid disorders, it is not known when comorbid conditions emerge in children with 
FXS. In order to better understand the emergence of these disorders, a study of the 
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precursors and underlying physiological mechanisms of these co-occurring disorders is 
needed.     
One such potential precursor is effortful control, which is broadly defined as the 
ability to regulate responses.  Deficits in effortful control exist in ADHD, ASD, and 
anxiety in typically developing populations (Nigg, 2006; Konstantareas & Stewart, 2006; 
Calkins & Fox, 2002). Physiological functioning, specifically the activity of the 
hypothalamic-pituitary-adrenal (HPA) axis, which is responsible for managing biological 
stress in humans, has been linked to the regulation of effortful control in typically 
developing children (Watamura, Donzella, Ketes, & Gunnar, 2004) and may serve as an 
underlying mechanism to the emergence of comorbid conditions in FXS.  
While effortful control deficits and HPA axis dysfunction are associated with 
ADHD, ASD, and anxiety in typically developing populations, the role of effortful 
control and HPA axis functioning in the emergence of ADHD, ASD, and anxiety is not 
well understood in typically developing children as well as children with FXS. Our initial 
work showed low levels of effortful control in boys with FXS that did not improve over 
time unlike typically developing boys that showed increased levels of effortful control 
over time (Robinson et al., in preparation).	  This dissertation includes two follow-up 
studies that examine how effortful control and HPA axis dysfunction relates to comorbid 
disorders within FXS.	  More specifically, the first study investigates the relationship 
between effortful control and HPA axis functioning, measured by salivary cortisol, in 
boys with FXS compared to boys with typical development. The subsequent study 
examines how effortful control and cortisol predict the emergence of ADHD, ASD, and 
anxiety symptoms in boys with FXS compared to typically developing boys.  
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The Neuroconstructivist Theory 
Existing work suggests that ADHD, ASD, and anxiety within FXS are best 
understood when behavioral and physiological factors are integrated within a 
developmental framework (Cornish et al., 2004). The neuroconstructivistic framework 
recognizes the role of genetics on brain development resulting in behavior and cognition 
that may change with development (Cornish et al., 2004; see Figure 1.1). This theoretical 
approach will be applied to the current studies to examine the potential precursors, 
mechanisms, and developmental course of ADHD, ASD, and anxiety in boys with FXS 
compared to boys with typical development. 
Emergence of ADHD, ASD, and Anxiety in FXS 
 ADHD, ASD, and anxiety are three of the most commonly co-occurring 
conditions in children with FXS (Bailey et al., 2008). Due to the high comorbidities, early 
identification is essential to prevent or minimize these secondary conditions to promote 
optimal outcomes. The study of precursors (i.e. effortful control) and underlying 
mechanisms (i.e. cortisol) will help build an understanding of the emergence of these co-
occurring disorders as well as the developmental pathways within FXS. 
ADHD. Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental 
disorder characterized by a pattern of symptoms of inattention and/or hyperactivity and 
impulsivity present across multiple settings (American Psychiatric Association, 2013). 
Symptoms of ADHD may include failure to pay close attention to details, difficulty 
organizing tasks and activities, excessive talking, fidgeting, or an inability to remain 
seated at appropriate times. Three subtypes of ADHD exist based on symptom 
composition: predominately inattentive presentation, predominately hyperactive-
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impulsive presentation, or combined presentation (inattention and hyperactive-impulsive 
symptoms). ADHD is the most prevalent childhood mental health diagnosis affecting 
over 6% of all children with even higher rates in clinical groups (CDC, 2013; American 
Psychiatric Association, 2013). Between 41% and 93% of children with FXS meet 
criteria on parent rating checklist for ADHD (see Sullivan et al., 2006 for review).  Of the 
subtypes of ADHD, children with FXS ages 7 to 13 years meet criteria for the inattentive 
presentation more than hyperactive-impulsive presentation or the combined presentation 
(Sullivan et al., 2006).  
There are several mechanisms that may affect the development of ADHD within 
FXS including age and intellectual level. At early ages, children with FXS display 
attention difficulties along with hyperactivity. As time progresses, the attention 
difficulties persist while hyperactivity decreases (Wheeler et al., 2014; Hagerman, 2002). 
Intellectual level may also play a large role in the emergence of comorbid FXS and 
ADHD; however, compared to other groups with intellectual disabilities including Down 
syndrome and idiopathic intellectual disability, boys with FXS exhibit higher rates of 
inattention, restlessness, distractibility, and impulsivity, suggesting that symptoms of 
ADHD are not limited to intellectual impairments (Turk, 1998).  
Co-occurring ADHD and FXS may result in severe social, academic, and adaptive 
behavior difficulties. Specifically, children with intellectual disabilities and ADHD 
experience greater restrictive school placements, increased school suspensions, and 
higher rates of inpatient psychiatric treatments compared to children with intellectual 
disabilities without ADHD (Faraone, Biederman, & Zimmerman, 2005; Handen, 
Janosky, & McAuliffe, 1997). As children with FXS and ADHD enter adulthood, they 
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are at increased risk for educational, mental health, and legal problems (Pearson et al., 
2003) suggesting the need for identification in childhood and treatment throughout the 
lifespan. In terms of treatment, stimulant medications used to target ADHD symptoms 
have been shown to increase academic, attention, and physiological regulation skills in 
boys with FXS (Roberts et al., 2011). While children with FXS and symptoms of ADHD 
may encounter increased negative experiences compared to children with FXS without 
symptoms of ADHD, positive effects are associated with targeted treatments. Therefore, 
a better understanding of the precursors and underlying mechanisms of ADHD can assist 
in the identification and treatment of ADHD symptoms in FXS.  
ASD. Autism spectrum disorder (ASD) is a neurodevelopmental disorder 
characterized by deficits in social communication and the presence of restricted, 
repetitive patterns of behavior, interest, or activities (American Psychiatric Association, 
2013). Social communication impairments may include deficits in social-emotional 
reciprocity, deficits in nonverbal communication, or deficits in developing, maintaining, 
or understanding relationships. Restricted and repetitive patterns of behavior, interest, or 
activities may consist of motor stereotypies, echolalia, lining up toys, difficulties with 
transitions, highly fixated interests, or hyper- or hypo-responsiveness to sensory input. 
ASD affects 1 in 68 children and 1 in 42 boys (CDC, 2015). A strong genetic correlate is 
evident within ASD as 10% of all children with ASD have a genetic or chromosomal 
condition including FXS (CDC, 2012). Ninety percent of males with FXS exhibit one or 
more symptom consistent with ASD and 60-75% of males and 20-45% of females with 
FXS meet criteria for ASD (Clifford et al., 2007; Hall, Burns, Lightbody, & Reiss, 2008; 
Harris et al., 2008; Klusek et al., 2014).  
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The most common symptoms of ASD displayed by children with FXS include 
language delays, poor eye contact, eye-gaze aversion, repetitive motor movements, 
atypical sensory responses, social avoidance, hyperarousal, impulsivity, and attentional 
impairments (Hatton et al., 2006;  Hessl et al., 2001; Kaufmann et al., 2004). Children 
with co-occurring FXS and ASD perform more similarly to children with idiopathic ASD 
than children with FXS-only suggesting the impact of ASD symptoms in children with 
FXS (Rogers et al., 2001). Co-occurring FXS and ASD leads to greater negative 
outcomes including lower levels of adaptive behavior, poorer developmental and 
intellectual abilities, greater problem behavior, delayed or reduced language skills, and 
lower social competence compared to individuals with FXS without ASD and children 
with idiopathic ASD (Cohen, 1995; Bailey et al., 2000; Rogers et al., 2001; Hatton et al., 
2002; Kau et al, 2004; Kaufman, 2004).  
Due to increased rates of ASD associated with increased impairment, the risk 
factors and underlying mechanisms of ASD continue to be studied. Intellectual level has 
been shown to predict ASD; however, over 60% of children with ASD do not have an 
intellectual disability; suggesting that IQ plays a limited role in the emergence of ASD 
(Charman et al., 2011; CDC, 2012). Autism symptoms persist across childhood (Elmose 
et al., 2013); however, few studies have examined the stability of ASD symptoms within 
FXS. Stability in the diagnostic classification (ASD versus no ASD) has been established 
within FXS (Hatton et al., 2006; Hernandez et al., 2009); however, ASD symptom 
severity has been found to increase over time (Hatton et al., 2006) and decrease slightly 
as social skills improved (Hernandez et al., 2009).  These studies illustrate the stability of 
ASD diagnoses (ASD versus no ASD), yet they do not clearly explain developmental 
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changes in ASD symptom severity that may occur within FXS (Hatton et al., 2006; 
Hernandez et al., 2009).  
Anxiety. Anxiety disorders are characterized by excessive and unrealistic worry 
about routine tasks or events, or to a specific object or ritual (American Psychiatric 
Association, 2013). Anxiety can be difficult to diagnosis in childhood as children 
experience developmentally appropriate fears and worries; therefore, anxiety disorders 
are identified when the fears and worries become excessive and/or unrealistic and 
interfere with daily functioning (Creswell, Waite, & Copper, 2014). Many anxiety 
disorders emerge during childhood with separation anxiety, generalized anxiety disorder, 
and social phobia being the most common (see Table 1.1 for description; American 
Psychiatric Association, 2013; Beesbo, Knappe, & Pine, 2011) Due to developmental 
changes in childhood fears and worries, anxiety symptoms differ across ages (Weems & 
Costa, 2005). Separation anxiety disorder is most prevalent in early childhood, typically 
emerging before age 5 and becoming rare in adolescence while generalized anxiety 
typically emerges around age 8 and increases in prevalence into adulthood (Copeland, 
Angold, Shanahan, & Costello, 2015; Weems & Costa, 2005). Social phobia is most 
prevalent in adolescents due to increased social demands and fears of failure and 
criticism (Weems & Costa, 2005). Significant homotypic and heterotypic continuity has 
been found in anxiety symptoms across childhood as young children with an anxiety 
disorders continue to meet criteria for an anxiety disorder at later ages; however, the 
specific anxiety disorder may change with age (e.g. separation anxiety disorder at age 5 
to generalized anxiety disorder in adolescence; e.g. Bufferd et al., 2012; Gregory et al., 
2007). Anxiety disorders in childhood are also linked to increased rates of anxiety and 
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depression in adulthood (Copeland et al., 2015; Woodward & Fergusson, 2001). 
Additionally, most adults with anxiety disorders experienced clinical levels of anxiety in 
childhood (Woodward & Fergusson, 2001).  
About 12% of children from non-clinical community samples meet criteria for an 
anxiety disorder at least once in their lifetime (Costello et al., 2011). Rates of anxiety are 
even higher in FXS as 86% of males (aged 5 to 26) and 76% of females meet diagnostic 
criteria for one or more anxiety disorder (Cordeiro, Ballinger, Hagerman, & Hessl, 2011). 
Based on these high prevalence rates within FXS, anxiety disorders are the second most 
commonly reported co-occurring disorder within FXS (Bailey et al., 2008; Cordeiro et 
al., 2011). Many individuals with FXS who do not meet diagnostic criteria for an anxiety 
disorder report features of anxiety disorders suggesting increased rates of anxiety 
symptoms within FXS and the continuum of symptoms associated with FXS (Cordeiro et 
al., 2011). Anxiety and social withdrawal have been shown to be core features of the FXS 
behavioral phenotype based on both parent and teacher reports (Sullivan et al., 2007). 
Anxiety symptoms within FXS most often manifest as avoidance behaviors, specific 
phobias, and compulsions (Sullivan et al., 2007); however, symptoms of generalized 
anxiety occur in higher functioning and older individuals with FXS (Kaufman, 2009). 
Social anxiety has also been shown to be a prominent symptom in individuals with FXS 
and may be a key feature in the co-occurrence of FXS and ASD (Kaufmann, Capone, 
Clarke, & Budimirovic, 2008; Simonoff et al., 2008). 
The study of precursors and underlying mechanism of anxiety within FXS is 
important to assist in the identification of anxiety within FXS in order to promote 
treatment. There are several mechanisms and precursors that may impact the 
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development of anxiety within FXS including age, effortful control, and HPA 
functioning. Anxiety disorders are highly heritable and have been found to persist across 
the lifespan (Bittner et al., 2007; Ferdinand, Dieleman, Ormel, & Verhulst, 2007). 
However, developmental changes in anxiety symptoms also exist. For example, 
separation anxiety decreases with age (Costello et al., 2011). Within FXS, anxiety 
symptoms show relative stability over time (Wheeler et al., 2014); however, age related 
changes in mechanisms related to anxiety exist in children with FXS as 
hyporesponsiveness is associated with infancy in FXS while hyperresponsiveness is 
associated with early childhood ages (Roberts, Tonnsen, Robinson, & Shinkareva, 2012).  
Due to evident developmental changes in anxiety symptoms in the general population as 
well as age related changes in mechanisms related to anxiety within FXS, the 
developmental trajectories of anxiety within FXS need further investigation.  
Anxiety disorders can be difficult to clinically diagnose in children with FXS as 
the diagnostic process often relies on verbal expression of symptoms, which may be 
lacking in children with intellectual impairments (Bailey et al., 2008). Many treatments 
and services for anxiety are linked to clinical diagnoses; therefore, some children with 
FXS may not receive the appropriate services needed if appropriate diagnoses are not 
made. Thus, children with FXS are not only at increased risk for displaying anxiety 
symptoms and developing anxiety disorders, but they are also at increased risk for not 
receiving targeted interventions (Bailey et al., 2008).  
Impaired Effortful Control: Potential Precursor to ADHD, ASD, and Anxiety 
Children with FXS exhibit impairments in effortful control that may serve as a 
precursor to ADHD, ASD, and anxiety. One conceptualization of effortful control is 
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through temperament, which is defined as individual differences in self-regulation, motor 
reactivity, and emotional reactivity (Rothbart & Derryberry, 1981; Rothbart & Bates, 
1998). The study of temperament allows for the investigation of constitutionally based 
biological and behavioral factors that have been associated with mental health outcomes 
(Rothbart & Derryberry, 1981; Rothbart & Bates, 1998).  A number of definitions and 
theories regarding temperament exist; however, the work of Mary Rothbart has the most 
solid empirical basis to date.  
Temperament factors are relatively stable over time yet influenced by 
development, heredity, and experience allowing for the study of early states as well as 
developmental changes (Rothbart & Derryberry, 1981; Rothbart & Bates, 1998). 
Effortful control reflects one’s ability to suppress or inhibit a dominant response to 
perform a subdominant response (Posner & Rothbart, 2000). Effortful control consists of 
two major components: inhibitory control, which reflects one’s ability to inhibit 
behavioral responses, and attentional control, which reflects one’s ability to focus and 
shift attention when needed (Muris & Ollendick, 2005). Effortful control emerges during 
the toddlerhood and early preschool years and continues to develop through childhood 
and adolescence in children with typical development (Posner & Rothbart, 2000).  
Effortful control impacts both behavioral and emotional development and, when 
impaired, it can lead to increased risk for negative outcomes. In typically developing 
children effortful control has been shown to be a risk factor for ADHD and anxiety (e.g. 
Murray & Kochanska, 2002; Nigg, 2006; Eisenberg et al., 2001) as low levels of effortful 
control relate to increased ADHD and anxiety symptoms. For example, in typically 
developing children (boys and girls) followed longitudinally from 2 years to 5 years of 
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age, lower levels of effortful control related to increased parent rated measures of 
attention problems at age 4 (Murray & Kochanska, 2002). Effortful control has also been 
shown to be the only temperament construct to differentiate children with ASD from 
typically developing children ages 3 to 10 as children with ASD exhibit reduced levels of 
effortful control (Konstantareas & Stewart, 2006). Additionally, in a study of boys ages 
10 to 15 years comparing levels of effortful control in three groups: boys with ADHD, 
boys with ASD, and typically developing boys, children in the clinical groups (ADHD/ 
ASD) scored significantly lower than typically developing children on measures of 
effortful control further supporting the link between effortful control deficits and the 
symptom manifestation of ADHD and ASD (Samyn, Roeyers, & Bijttebier, 2011). The 
relationship between effortful control and anxiety symptoms has limited empirical 
support compared to symptoms of ADHD and ASD. In a longitudinal study of typically 
developing children ages 5 to 9, lower levels of effortful control related to increased 
internalizing symptoms at ages 5 and 7 but not at age 9 (Eisenberg, Sadovsky, et al., 
2005). Additionally, adolescents with anxiety disorders displayed lower levels of effortful 
control compared to controls (Vervoort et al., 2011). Effortful control served as a 
protective factor for the adolescents with anxiety as higher levels of effortful control 
related to decreased internalizing symptoms (Vervoort et al., 2011). While the 
relationship between impaired effortful control and anxiety symptoms has been 
established in adolescents, very little research has investigated the link between effortful 
control and anxiety in young children. Overall, reduced levels of effortful control may 
serve as a risk factor for ADHD, ASD, and anxiety in children.  
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The study of effortful control in FXS is relatively new. A factor analytic study of 
the temperament factors of the Child Behavior Questionnaire (i.e. negative affectivity, 
surgency/ extraversion, and effortful control; Rothbart, Ahadi, Hershey, & Fisher, 2001) 
revealed a factor structure within FXS similar to the original Rothbart factor structure in 
typically developing children supporting the application of Rothbart’s factor structure in 
the current studies (Roberts, Tonnsen, Robinson, McQuillin, & Hatton, 2013). Children 
with FXS typically display lower levels of effortful control across ages compared to 
typically developing children and show no changes in levels of effortful control over time 
unlike typically developing children who show a steady increase across ages (Robinson et 
al., in preparation; Posner & Rothbart, 2000). Additionally, greater autism symptoms 
have been found to relate to lower levels effortful control in young boys with FXS 
(Robinson et al., in preparation). The relationship between effortful control and ADHD 
and anxiety symptoms in children with FXS has not been examined to date. Overall, 
children with FXS exhibit impairments in effortful control across ages, which may serve 
as a precursor for mental health disorders as is observed in children with typical 
development. However, effortful control has not been examined as a potential precursor 
to ADHD, ASD, and ADHD symptoms in children with FXS.  
Physiological Functioning: Potential Mechanism in ADHD, ASD, and Anxiety 
The relationship between physiological functioning and behavior is complex and 
multifaceted.  Theoretical advances, like the neuroconstructivist model, have facilitated 
this work in FXS with recognition of the multiple etiological mechanisms for disorders 
including genetic, neurobiological, and environmental factors that operate in a 
transactional manner over time. There are numerous reasons to incorporate physiological 
	  
14 
processes in research of typically developing individuals and those with 
neurodevelopmental disabilities like FXS. First, physiological data may help identify 
underlying relevant physiological mechanisms in the absence of clear overt behavioral 
symptoms. Second, physiological measures can provide a measure of response that may 
not otherwise be available which is particularly relevant in very young children or those 
with limited language or cognitive function.  Third, physiological markers can document 
biological vulnerability to later-emerging symptoms or disorders both within and across 
etiologically-specific groups. Finally, physiological markers may reflect individual 
differences that could affect treatment response.  
While a number of physiological systems are implicated in the regulation of 
effortful control, the hypothalamic- pituitary-adrenal (HPA) axis has been a focus given 
its role in managing biological stress responses in humans. As part of the neuroendocrine 
system, the HPA axis plays a critical role in an organism’s ability to adapt to 
biopsychosocial challenges (McEwen, 2004). When stressed, the HPA axis stimulates the 
hypothalamus to secrete corticotrophin-releasing hormone (CRH), which causes the 
pituitary to release ACTH that ultimately stimulates the adrenal gland to secrete the 
hormone cortisol. Cortisol is used to measure stress and is found in plasma but can also 
be reliably measured in saliva. The activity of the HPA axis system is part of normal 
coping and stress regulation (Gunnar, 1987); however, HPA axis dysfunction, including 
both under- and over-activity, leads to negative effects on brain development resulting in 
learning, memory, and attention deficits (see Sandi & Pinelo-Nava, 2007 for review). 
This suggests an inverse U-shaped relationship between cortisol levels and cognitive 
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functioning exists such that significantly high and significantly low levels of cortisol lead 
to impairments. Optimal performance is linked with moderate levels of cortisol.  
HPA axis dysfunction is common in many clinical groups including those with 
ADHD, ASD, and anxiety disorders. Specifically, children with ADHD alone tend to 
exhibit reduced levels of cortisol compared to typically developing children in the 
morning, at bedtime, and during stressful events (Isaksson, Nilsson, Nyberg Hogmark, & 
Lindblad, 2012; Ma et al., 2011; Isaksson, Nilsson, Lindbald, 2013). Children with ASD 
also display HPA axis dysfunction. In a study evaluating stress regulation during 
psychosocial stress situations, typically developing children showed significant decreases 
in stress over time while children with ASD exhibited increased cortisol levels following 
the stress situation suggesting impairments in stress regulatory abilities for children with 
ASD (Corbett, Schupp, & Lanni, 2012). However, when not encountering a stressful 
situation, children with ASD tend to exhibit reduced levels of cortisol compared to 
typically developing children (Ćurin, Terzić, Petković, et. al, 2003).  High baseline 
cortisol levels (see Costello et al., 2011 for review) have been shown to serve as risk 
factors for the development of anxiety. Overall, anxiety disorders are typically associated 
with chronically high levels of cortisol (Costello et al., 2011) while children with ADHD 
and ASD typically exhibit reduced levels of cortisol (e.g. Ma, Chen, Chen, Liu, & Wang, 
2011;  Ćurin, Terzić, Petković, et. al, 2003). Due to the known link between 
physiological functioning and mental health disorders, HPA axis activity may operate as 
an underlying mechanism of ADHD, ASD, and anxiety suggesting that over- or under-
activity of the HPA axis may lead to impairments in behavior regulation consistent with 
symptoms of ADHD, ASD, or anxiety.  
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HPA axis dysfunction is evident in children with FXS. Specifically, boys with 
FXS tend to have chronically high levels of cortisol compared to typically developing 
children suggesting increased arousal and stress reactivity (Wisbeck et al. 2000; Hessl et 
al., 2002; Hessl, Glaser, Dyer-Friedman, & Reiss, 2006; Hessl, Rivera, & Reiss, 2004). 
These high levels of cortisol have also been linked to symptoms of ADHD and anxiety 
within FXS in some studies (Hessl et al., 2002) but not others (Hessl, Glaser, Dyer-
Friedman, & Reiss, 2006). Conversely, reduced levels of cortisol have been found to 
relate to ASD specific symptoms in boys with FXS (Hall et al., 2008). Compared to 
typically developing children and boys with FXS and no ASD, boys with co-occurring 
FXS and ASD are less able to regulate their response to a stressful event which was 
associated with elevated initial levels that may have constrained reactivity (Roberts et al., 
2009). These results suggest impairments in normal HPA axis functioning in children 
with FXS. These elevated or decreased releases of cortisol may serve as an underlying 
mechanism of effortful control impairments leading to the emergence of ADHD, ASD, or 
anxiety.  
There is both theoretical and empirical evidence to link effortful control and HPA 
axis function given that they both represent aspects of regulation. Children with typical 
development with higher levels of effortful control produced lower levels of baseline 
cortisol when controlling for age in typically developing children ages 12 to 36 months 
(Watamura, Donzella, Ketes, & Gunnar, 2004). Additionally, higher levels of cortisol 
during a challenging situation relate to lower levels of effortful control in children of 
typical development suggesting that increased HPA axis functioning may serve as an 
underlying mechanism of effortful control with high levels signaling poor physiological 
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regulation (Dettling, Parker, Lane, Sebanc, & Gunnar, 2000).  While the relationship 
between cortisol and effortful control has been established in typically developing 
samples, this link has yet to be studied within FXS supporting the need for this study 
focused on such factors.  
Current Studies 
ADHD, ASD, and anxiety are complex mental health disorders that require the 
integration of behavioral and physiological factors to fully understand their emergence 
and development over time. Due to the increased rates of ADHD, ASD, and anxiety 
disorders within FXS and even higher rates of symptoms of these disorders, this single-
gene disorder provides an ideal model to study precursors and underlying mechanisms of 
these disorders. Using a neuroconstructivistic approach, the following sequential studies 
used a dimensional approach to assess the precursors and underlying mechanisms of 
ADHD, ASD, and anxiety symptoms within FXS. The neuroconstructivistic approach 
highlights the bi-directional nature of multiple factors suggesting that precursors to these 
mental health disorders interact with one another over time. Therefore, the following 
sequential studies aimed to examine the role of development in the emergence and 
stability of ADHD, ASD, and anxiety symptoms. The first study examined whether 
physiological dysfunction, as measured by cortisol, serves an underlying mechanism of 
effortful control impairments in children with FXS compared to typically developing 
children. The subsequent study examined how impaired effortful control and 
physiological dysfunction relate to the emergence of ADHD, ASD, and anxiety in boys 
with FXS compared to typically developing boys.  
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Study 1: What is the relationship between effortful control and cortisol in young 
boys with FXS compared to typically developing boys controlling for chronological 
age and developmental level? 
It is hypothesized that boys with FXS will exhibit lower levels of effortful control and 
increased cortisol levels compared to typically developing boys. A negative relationship 
between effortful control and cortisol is anticipated for both groups.  
Study 2: Does effortful control and cortisol predict the emergence of ADHD, ASD, 
or anxiety symptoms in young boys with FXS compared to typically developing boys 
while controlling for chronological age and developmental level?   
It is hypothesized that children with FXS will exhibit higher levels of ADHD, ASD, and 
anxiety symptoms with relative stability across ages.  Lower levels of effortful control are 
hypothesized to predict higher levels of ADHD, ASD, and anxiety symptoms in both 
groups. Higher levels of cortisol are expected to relate to increased levels of anxiety 
symptoms. Lower levels of cortisol are expected to relate to increased levels of ADHD 
and ASD symptoms.  
The current dissertation included two sequential studies that overlap but are not 
identical. Due to differences in sample sizes and measures used, the methods and results 
are discussed for each study separately. While these studies have slight differences, they 




Table 1.1. Description of Anxiety Disorders in Childhood 
Anxiety Disorder Description 
Separation Anxiety Disorder 
excessive worry about separation from a major 
attachment figure 
Generalized Anxiety Disorder 
excessive and uncontrolled worry across 
multiple situations and activities 
Social Phobia 
intense and persistent fear of social or public 
situations 
(American Psychiatric Association, 2013) 
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Table 1.2. Labels and definitions of scales comprising effortful control.   
 
 
Definition ECBQ* CBQ* 
Attention 
Focusing 





Capacity to shift attention from on task or 




Ability to suppress actions or responses. X X 
Low-Intensity 
Pleasure 
Enjoyment or pleasure resulting from 
stimuli of low intensity, rate, complexity, 




Ability to detect slight, low-intensity 
stimuli from the environment.  
 X 
Cuddliness 





Positive affect related to changes in 
stimulus intensity, rate, complexity, and 
incongruity 
 X 











STUDY 1  
2.1 METHODS 
Participants  
Participants for the current study included 46 males with FXS and 17 typically 
developing males (TD). Participants were drawn from two existing datasets. The first is 
an extant dataset of a series of longitudinal studies on the early development of children 
with FXS from the University of North Carolina. The second is from an ongoing study at 
the University of South Carolina focusing the early emergence of ASD in young children 
with FXS. For both the UNC and USC studies, recruitment of participants took place 
through research registries, mailings, and listserve emails.  Criteria for the current study 
included the participants’ first assessment after the age of 17 months with data from a 
parent-rated temperament questionnaire, parent interview, and salivary samples. This 
early assessment time was chosen due to the study goals of examining the emergence of 
behaviors. Typically developing children were identified as those without any suspected 
or identified delays or disabilities as well as no history of FXS. These children also 
scored within two standard deviations of the mean on a measure of developmental level. 
The typically developing group was matched with the FXS participant group on a broad 
age range. Only males were included in the current study due to greater heterogeneity in 
the phenotype of females with FXS. Participants with FXS ranged in age from 18 months 
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to 7 years (M=4.21, SD=1.64) while TD participants ranged in age from 18 months to 4 
years (M=2.72, SD=1.64). See Table 2.1 for an overview of the data.  
Measures 
 Effortful Control. Parent-rated temperament questionnaires measuring aspects of 
reactivity and self-regulation were collected at each assessment. To best examine 
temperament longitudinally across childhood, multiple temperament scales were 
developed to appropriately account for developmental changes. Due to the longitudinal 
nature of the current study, two temperament scales were used including the Early 
Childhood Behavior Questionnaire (ECBQ; Putnam, Gartstein, & Rothbart, 2006) and 
the Child Behavior Questionnaire (CBQ; Rothbart et al., 2001). The ECBQ is used for 
children ages 16 to 35 months while the CBQ is used for children ages 3 to 7 years.   
Factor analytic studies exist for the scales and the following three temperament 
constructs are consistently reported: effortful control, surgency/extraversion, and negative 
affectivity (Putnam et al., 2006; Putnam, Rothbart, & Garstein, 2008; Rothbart et al., 
2001).   The current study focused on effortful control and computed this construct using 
the scales with the highest factor loadings per published findings. While the ECBQ, and 
CBQ are theoretically unified, item and scale content overlap but are not identical given 
the change in behavioral expression associated with developmental factors (e.g., attention 
focusing in toddler aged children is expressed differently than attention focusing for 
children in middle childhood). Thus, there are minor differences in the factor composition 
of effortful control across scales reflecting this developmental effect (see Table 1.2 for 
review).  For the ECBQ, effortful control is comprised of attention focusing, attentional 
shifting, inhibitory control, low-intensity pleasure, and cuddliness (see Table 1.2 for scale 
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definitions; Putnam, Garstein, & Rothbart, 2006), while the CBQ effortful control 
composite is comprised of attention focusing, inhibitory control, low-intensity pleasure, 
perceptual sensitivity, and smiling and laughter (Rothbart et al., 2001).  
 These temperament scales have been extensively evaluated and show strong 
convergent and discriminate validity, inter-rater reliability, internal reliability, and 
reliability across ages (Putnam, Rothbart, & Garsten, 2008). Effortful control in early 
childhood predicts effortful control in later childhood suggesting strong homotypic 
continuity (Putnam, Rothbart, & Garstein, 2008). Consistent with previous work, the 
effortful control scale was computed by taking the mean of the standardized temperament 
scales (see Table 1.2). For the current study, internal reliability estimates of effortful 
control ranged from .54 to .84. For the FXS group, effortful control scores ranged from -
2.24 to 1.19 (M=-0.25, SD=0.9). For the TD group, effortful control scores ranged from -
0.77-2.33 (M=0.67, SD=0.93).  
  Salivary Cortisol. Salivary samples were collected two times during each 
assessment to measure cortisol.  The current study used only the first salivary sample 
termed “baseline cortisol,” which was collected within 15 minutes of the start of the 
assessment to represent pre-assessment cortisol levels. The second salivary sample 
termed “reactivity” was not included in the current study for two reasons. First, the 
current study aimed to explore the role of HPA axis functioning when not undergoing a 
stressful situation. Secondly, the reactivity sample was missing for many of the 
participants in the current study significantly limiting the sample size. The salivary 
samples were collected using a Salivette (Salimetrics, LLC 2005), which resembles an 
oral cotton swab that the participant saturated in his mouth for at least one minute.   
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Participants were asked to avoid consumption of food or liquid (except water) 30 minutes 
before the sample.  Assessment times were scheduled to start and end at the approximate 
same time each day and the collection time was recorded to control for diurnal variation 
in cortisol levels. The saliva samples were processed using the Salimetrics’ Salivary 
Cortisol Enzyme Immunoassay kit (EIA; Salimetrics LLC, 2005). Serum and saliva 
cortisol are positively correlated using the Salimetrics EIA (r=.91, p<.0001; Salimetrics 
LLC, 2005). The mean inter-assay coefficient of variation for the current sample was 
6.53 (Range=5.40- 8.11%) Each sample was assayed twice and the correlations among 
the assays was >.95. Cortisol levels are reported in micrograms/deciliter. Across all 
observations, cortisol levels varied from 0.04 to 1.79 (M=0.28, SD=0.3) for the FXS 
group and 0.04 to 0.52 (M=0.11, SD=0.11) for the TD group. 
Developmental Level. The Vineland Adaptive Behavior Scale (VABS; Sparrow, 
Balla, Cicchetti, & Doll, 1984; VABS- 2; Sparrow, Cicchetti, & Balla, 2005) is a semi-
structured interview that measures adaptive behavior skills in 4 domains: communication, 
socialization, daily living skills, and motor skills. Mothers completed the interview of 
their child’s current abilities at each assessment. Domain and adaptive behavior 
composite (ABC) standard scores were calculated. For the current study, two versions of 
the Vineland were used due to the release of an updated version during the data collection 
period. The VABS has been extensively used with typically developing and clinical 
populations. Test-retest reliability estimates vary around .80 suggesting stability over 
time. Uniformality among raters has also been found as inter-rater reliability estimates 
range from .6 to .7. In terms of validity, the VABS has been shown to correlate well with 
other measures of adaptive behavior including Adaptive Behavior Inventory for Children 
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(ABIC; .58) and AAMD Adaptive Behavior (.40 to .70). Overall, the VABS is a robust 
well-supported measure of developmental skills for children. The VABS is commonly 
used as a measure of development in children with FXS as it can be very difficult to 
obtain valid intelligence scores (Rogers et al., 2001; Hatton et al., 2006; Kaufman et al., 
2004). This scale is also widely used with children with ASD and has been shown to 
positively correlate with measures of cognitive ability and mental age in children with 
ASD supporting the use of this scale in the current study (Wells, Condillac, Perry, & 
Factor, 2009; Freeman, Del’Homme, Guthrie, & Zhang, 1999). In the current sample, 
ABC scores ranged from 36 to 119 for the FXS group (M=60.39, SD=13.62) while the 
total scores for the TD group ranged from 85 to 114 (M=100.59, SD=8.62). These ABC 
scores were found to highly correlate (r=0.91) with a concurrent and direct assessment of 
developmental skills measured by the Early Learning Composite score of the Mullen 
Early Scales (Mullen, 1995).  
Procedures 
The effortful control and salivary cortisol measures were all completed within a 
larger assessment battery. Interested parents were provided with study information over 
the phone and through email. All children who met the inclusion/exclusion criteria were 
enrolled in the study. Informed consent was completed for each participant by the parent 
and the individual assessments were conducted within the family home. The parent rated 
scales were completed within two weeks before or after the in-person assessment. 
Following each assessment, families were given a small stipend and a summary report of 
their child’s developmental skills. All data were scored and double-checked at 100%. The 




All analyses were performed using the R Project for Statistical Computing and the 
NLME package (version 2.14.2; R Foundation for Statistical Computing, 2012). To 
address the hypotheses, analyses were conducted through a series of steps. First, 
descriptive analyses and correlations were conducted. Second, initial analyses of 
covariance (ANCOVA) and linear regression models were built to examine potential 
predictors. The final step included determining the models with the best fit. Diagnostic 
analyses of the data were performed to examine the key assumptions of ANCOVA and 
linear regression.  Plots of residual and error terms supported the independence and 
normality of residuals, homoscedasticity of variance, and homogeneity of regression 
slopes. No influential data points were found, including outliers. Due to a skewed 
distribution, cortisol was transformed using a log base 10 transformation. 
Analyses of covariance (ANCOVA) were conducted to compare mean levels of 
effortful control and cortisol across the FXS and TD groups controlling for age. 
Developmental level was tested as a covariate but was not independent of group 
membership so it was not included in the ANCOVA. Multiple linear regression models 
were conducted to assess the relationship between effortful control and cortisol. The final 
model included cortisol predicting effortful control while controlling for age, 
developmental level, and group membership. , Y=B0+ B 1(Age)+ B 2(Developmental 
Level)+ B 3(Group)+ ßB4(Cortisol)+ ei, Interaction effects were tested examining the role 
of group membership, age, and developmental level with cortisol.; however, due to 
decreased model fit and non-significant findings, these interaction effects were not 




ANCOVA results revealed that when controlling for age, boys with FXS 
exhibited significantly lower levels of effortful control (M=-0.25, SD=0.9) compared to 
typically developing boys (M=0.67, SD=0 .93, F(2,60)=12.11, p<.0001). Boys with FXS 
exhibited significantly higher levels of cortisol (M=0.28, SD=0.3) compared to boys with 
typical development (M= 0.11, SD= 0.11, F(2,60)=14.85, p=.0003) when controlling for 
age. Figure 2.1 illustrates this comparison.  
The results (Table 2.2) of the linear regression model examining the relationship 
between cortisol and effortful control indicated that when controlling for age, 
developmental level, and group membership, cortisol levels did not significantly predict 
effortful control (B=0.22, p=0.53). Increasing age (B=0.24, p=0.01) and developmental 
level (B=0.03, p=.005) did significantly predict higher levels of effortful control. Due to 
the null finding, a post-hoc power analysis using R was conducted and indicated a 
11.56% chance of detecting a small effect (.02), a 64.73% chance of detecting medium 
effect (.15) and a 96.66% chance of detecting a large effect (.35) based on the sample size 
(n=63), model predictors (df=4), and significant level (p=.05). These results suggest that 




Table 2.1. Study 1 Descriptives 
 Group 
 FXS (n=46) TD (n=17) 
 M (SD) Range M (SD) Range 
Age (years) 4.21 (1.64) 1.47 – 7.81 2.76 (0.78) 1.54 – 4.15 
Developmental Level  60.39 (13.62) 36 – 119 100.59 (8.62) 85 – 114 
Effortful Control -0.25 (0.9) -2.24 – 1.19 0.67 (0.93) -0.77 – 2.33 
Cortisol 0.28 (0.3) 0.04 -1.79 0.11 (0.11) 0.04 – 0.52 






Table 2.2. Linear Regression Results, Outcome: Effortful Control 




Variable B SE t-value p F df p R2 
Intercept -3.01 1.15 -2.61 0.01 7.02 4, 58 0.0001 0.30 
Age (years) 0.24 0.08 2.87 0.005     
Developmental 
Level 





Group -0.06 0.44 -0.14 0.89     




Figure 2.1. Group comparisons of mean levels of effortful control and cortisol. 
	  









Participants for the current study included 60 males with FXS assessed between 1 
and 3 times and 34 males with typical development (TD) assessed between 1 and 2 times 
with a one-year interval between all assessments. Participants were drawn from two 
existing datasets. The first is an extant dataset of two longitudinal studies on the early 
development of children with FXS from the University of North Carolina. The second is 
from an ongoing study at the University of South Carolina focusing the early emergence 
of ASD in young children with FXS.   For both the UNC and USC studies, recruitment of 
participants took place through research registries, mailings, and listserve emails.  
The current study included participants with FXS and of typical development with 
data from a parent-rated temperament questionnaire, a parent-rated behavior 
questionnaire, salivary samples, a parent interview of developmental disabilities, and 
observer ratings of ASD symptoms. Typically developing children were identified as 
those without any suspected or identified delays or disabilities as well as no history of 
FXS. These children also scored within two standard deviations of the mean on a 
measure of developmental level. Typically developing boys were matched within a broad 
chronological age range (1.5- 5 years). Only males were included in the current study due 
to greater heterogeneity in the phenotype of females in females with FXS.  
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Participants with FXS were assessed between 1 and 3 times totaling 118 
observations  (Time 1: N= 60, Time 2: N=42, Time 3: N=16) while the TD participants 
were assessed one to two times yielding 39 total observations (Time 1: N=34, Time 2: 
N=5). See Table 3.1 for an overview of the observations.  Across all observations, 
participants with FXS ranged in age from 18 months to 5.9 years (M=4.14, SD= 1.09) 
while the typically developing group ranged in age from 23 months to 4.5 years (M=3.12, 
SD= 0.81). Table 3.2 reports the characteristics of the participants at the first observation 
by group.  
Measures 
 ADHD and Anxiety Symptoms. Symptoms of ADHD and anxiety were assessed 
using the Child Behavior Checklist (CBCL; Achenbach, 1991; Achenbach & Rescorla, 
2001). The CBCL is a parent-rated measure of adaptive and maladaptive behaviors. 
When completing the scale, parents were asked to think about their child’s behavior over 
the past 6 months. This widely used measure assesses several areas of behavioral and 
emotional functioning in children age 1.5 to 18 years. The version for ages 1.5 to 5 years 
was used in the current study to best assess the emergence of ADHD and anxiety 
symptoms. A large normative sample was collected for the CBCL. Strong reliability and 
validity has been documented with estimates of test-retest reliability at r=.95 (Achenbach 
and Rescorla 2001; Achenbach et al. 2003). The CBCL is frequently used with children 
with FXS (Tonnsen et al., 2013; Hatton et al., 2002; Kau et al., 2004). For the current 
study, two specific scales were drawn from both forms that assess the diagnostic criteria 
of ADHD and anxiety disorders based on the Diagnostic and Statistical Manual of Mental 
Disorders, 4th edition (American Psychiatric Association, 1994). High internal reliability 
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estimates of .85 for the ADHD problems scale and .77 for the anxiety problems scale 
have been reported (Nakamura, Ebesutani, Bernstein, & Chorpita, 2008).  
For the DSM-specific scales, raw scores are converted to T-scores that rank in 
average range (≤65), borderline clinical range (66-69), or clinically significant range 
(≥70). The average T-score for ADHD symptoms was for the FXS group 59.18 
(SD=6.96, range=50-76) and 52.38 (SD=3.57, range=50-64) for the TD group. In the 
FXS group, 22.5% percent (n=18) of the participants had elevated ADHD scores at one 
or more assessment and no participants in the TD group had ADHD T-scores above 65. 
The average T-score for anxiety symptoms was 55.55  (SD=7.83, range= 50-86) for the 
FXS group and 52.69 (SD=5.43, range=50-73) for the TD group. Seven FXS participants 
(8.75%) had anxiety T-scores above 65 at one or more assessment while two participants 
(0.06%) in the TD group had elevated anxiety scores.  
The publisher recommends using raw scores in research as the T-scores are 
truncated at 50 (Achenbach, 1991) resulting in a floor effect. For the current sample, the 
average raw score for ADHD symptoms was 7.33 for FXS group (SD=2.71, range= 0-16) 
and 4.15 for the TD group (SD=2.21, range=1-9). For children with FXS, the average raw 
score for anxiety 3.78 (SD=2.44, range= 0-15) and 2.59 for the TD group (SD=2.44, 
range=0-10). Raw scores were standardized for all analyses.  
ASD Symptoms. The Childhood Autism Rating Scale (CARS; Schopler, 
Reichler, DeVellis, & Daly, 1980) is an examiner rating scale of behavioral symptoms of 
ASD. Children are rated in 15 areas related to ASD characteristics including social 
behaviors, activity level, adaptation, and communication. A composite score of 15 to 60 
is obtained from the sum of the items yielding a measure of symptom severity and ASD 
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diagnoses are consistent with scores of 30 or above. The CARS was completed by 
examiners following each assessment based on behaviors observed as well as on parent 
reported behaviors. The CARS is a well-established measure with extensive reliability 
and validity evidence (Schopler, Reichler, DeVellis, & Daly, 1980). The measure has 
high internal consistency ratings above .90, inter-rater reliability estimates around .71, 
test-retest reliabilities ranging from .90 at one year apart to .77 at two years. Furthermore, 
strong sensitivity and specificity values of .88 or higher support the accuracy of the 
instrument in identifying individuals with and without ASDs. Although not an ASD 
diagnostic measure, the CARS is often used in research settings to assess ASD behaviors 
in children with FXS (Hatton et al., 2006; Shanahan, Roberts, Hatton, Reznick, & 
Goldsmith, 2008). The CARS is standardized on children ages 2 and up. Due to the age 
restriction, observations before 24 months were removed from the ASD symptoms 
analyses.  
In the current sample, CARS scores ranged from 16.5 to 42 for the FXS group 
(M=27.09, SD=5.47) while the total scores for the TD group ranged from 15 to 29 
(M=16.06, SD=2.7). Twenty-six of the FXS participants (32.5%) had scores of 30 or 
higher at one or more assessment.  No participants in the TD group had CARS scores 
above 29.  
Effortful Control. Parent-rated temperament questionnaires measuring aspects of 
reactivity and self-regulation were collected at each assessment. To best examine 
temperament longitudinally across childhood, multiple temperament scales were 
developed to appropriately account for developmental changes. Due to the longitudinal 
nature of the current study, two temperament scales were used including the Early 
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Childhood Behavior Questionnaire (ECBQ; Putnam, Gartstein, & Rothbart, 2006) and 
the Child Behavior Questionnaire (CBQ; Rothbart et al., 2001). The ECBQ is used for 
children ages 16 to 35 months while the CBQ is used for children ages 3 to 6 years.  For 
all scales, mothers indicated how often their child displayed specific behaviors based on a 
scale of 1 (never) to 7 (always).  
Factor analytic studies exist for the scales and the following three temperament 
constructs are consistently reported: effortful control, surgency/extraversion, and negative 
affectivity (Putnam et al., 2006; Putnam, Rothbart, & Garstein, 2008; Rothbart et al., 
2001).  The current study focused on effortful control and computed this construct using 
the scales with the highest factor loadings per published findings. While the ECBQ and 
CBQ are theoretically unified, item and scale content overlap but are not identical given 
the change in behavioral expression associated with developmental factors (e.g., attention 
focusing in toddler aged children is expressed differently than attention focusing for 
children in middle childhood). Thus, there are minor differences in the factor composition 
of effortful control across scales reflecting this developmental effect (see Table 1.2 for 
review).  For the ECBQ, effortful control is comprised of attention focusing, attentional 
shifting, inhibitory control, low-intensity pleasure, and cuddliness (see Table 1.2 for scale 
definitions; Putnam, Garstein, & Rothbart, 2006), while for the CBQ, effortful control 
composite is comprised of attention focusing, inhibitory control, low-intensity pleasure, 
perceptual sensitivity, and smiling and laughter (Rothbart et al., 2001). 
 These temperament scales have been extensively evaluated and show strong 
convergent and discriminate validity, inter-rater reliability, internal reliability, and 
reliability across ages (Putnam, Rothbart, & Garsten, 2008). Effortful control in early 
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childhood predicts effortful control in later childhood suggesting strong homotypic 
continuity (Putnam, Rothbart, & Garstein, 2008). Consistent with previous work, 
effortful control scale was computed by taking the mean of the standardized temperament 
scales (see Table 2). For the current study, internal reliability estimates of effortful 
control ranged from .70 to .87.  Across all observations, levels of effortful control varied 
from -2.74 to 2.16 (M=-0.22, SD= 0.96) for the FXS group and -0.97 to 2.35 (M=0.68, 
SD=0.8) for the TD group.  
  Salivary Cortisol. Salivary samples were collected two times during each 
assessment to measure cortisol.  The current study used the first salivary sample termed 
“baseline cortisol,” which was collected within 15 minutes of the start of the assessment 
to represent pre-assessment cortisol levels. The second salivary sample termed 
“reactivity” was not included in the current study for two reasons. First, the current study 
wanted to explore the role of HPA axis functioning when not undergoing a stressful 
situation. Secondly, the reactivity sample was missing for many of the participants in the 
current study significantly limiting the sample size and power.  The salivary samples 
were collected using a Salivette (Salimetrics, LLC 2005), which resembles an oral cotton 
swab that the participant saturated in his mouth for at least one minute. Participants were 
asked to avoid consumption of food or liquid (except water) 30 minutes before the 
sample. Assessment times were scheduled to start and end at the approximate same time 
each day and the collection time was recorded to control for diurnal variation in cortisol 
levels. The saliva samples were processed using the Salimetrics’ Salivary Cortisol 
Enzyme Immunoassay kit (EIA; Salimetrics LLC, 2005). Serum and saliva cortisol are 
positively correlated using the Salimetrics EIA (r=.91, p<.0001; Salimetrics LLC, 2005). 
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The mean inter-assay coefficient of variation for the current sample was 6.53 
(range=5.40- 8.11%). Each sample was assayed twice and the correlations among the 
assays was >.95. Cortisol levels are reported in micrograms/deciliter. Cortisol levels were 
included for the first time point for a subset of the sample (FXS N: 25; TD N: 21) due to 
missing data at subsequent assessment times. Cortisol levels varied from 0.04 to 1.75 
(M=0.33, SD=0.34) for the FXS group and 0.04 to 0.52 (M=0.14, SD=0.13) for the TD 
group. 
Developmental Level. The Vineland Adaptive Behavior Scale (VABS; Sparrow, 
Balla, Cicchetti, & Doll, 1984; VABS- 2; Sparrow, Cicchetti, & Balla, 2005) is a semi-
structured interview that measures adaptive behavior skills in 4 domains: communication, 
socialization, daily living skills, and motor skills. Mothers completed the interview of 
their child’s current abilities at each assessment. Domain and adaptive behavior 
composite (ABC) standard scores were calculated. For the current study, two versions of 
the Vineland were used due to the release of an updated version during the data collection 
period. The VABS has been extensively used with typically developing and clinical 
populations. Test-retest reliability estimates vary around .80 suggesting stability over 
time. Uniformality among raters has also been found as inter-rater reliability estimates 
range from .6 to .7. In terms of validity, the VABS has been shown to correlate well with 
other measures of adaptive behavior including Adaptive Behavior Inventory for Children 
(ABIC; .58) and AAMD Adaptive Behavior (.40 to .70). Overall, the VABS is a robust 
well-supported measure of developmental skills for children. The VABS is commonly 
used as a measure of development in children with FXS as it can be very difficult to 
obtain valid intelligence scores (Rogers et al., 2001; Hatton et al., 2006; Kaufman et al., 
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2004). This scale is also widely used with children with ASD and has been shown to 
positively correlate with measures of cognitive ability and mental age in children with 
ASD supporting the use of this scale in the current study (Wells, Condillac, Perry, & 
Factor, 2009; Freeman, Del’Homme, Guthrie, & Zhang, 1999). In the current sample, 
ABC scores ranged from 33 to 85 for the FXS group (M=58.25, SD=9.26) while the total 
scores for the TD group ranged from 85 to 118 (M=100, SD=9.14). These ABC scores 
were found to highly correlate (r=0.84) with a concurrent and direct assessment of 
developmental skills measured by the Early Learning Composite score of the Mullen 
Early Scales (Mullen, 1995).  
Procedures 
The parent rated temperament and behavior scales, developmental measures, 
examiner rating, and salivary samples were all completed within a larger assessment 
battery.  Interested parents were provided with study information over the phone and 
through email. All children who met the inclusion/exclusion criteria were enrolled in the 
study. Informed consent was completed for each participant by the parent and the 
individual assessments were conducted within the family home. The parent rated scales 
were completed within two weeks before or after the in-person assessment. Following 
each assessment, families were given a small stipend and a summary report of their 
child’s developmental skills. All data were scored and double-checked at 100%. The data 
were then double-entered and verified for 20% accuracy.  
Data Analysis 
The primary goal of this study was to compare the trajectories of ADHD, ASD, 
and anxiety symptoms in boys FXS compared to typically developing children and to 
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examine the unique roles that effortful control and cortisol play in these trajectories.  
Multilevel modeling (MLM) was used to analyze participants’ trajectories using the R 
Project for Statistical Computing and the NLME package (version 2.14.2; R Foundation 
for Statistical Computing, 2012). MLM is a strong method for conceptualizing individual 
change over time because it uses a single analysis of repeated measures data patterns 
(Raudenbush & Bryk, 2002). MLM uses a two-level hierarchical model of within- (Level 
1) and between- (Level 2) subject variances to model change and continuity over time. 
The Level 1 includes the intercept, which models the individual’s status at the mean age, 
and slope, which models the individual’s growth rate. Level 2 describes differences 
between individuals in these parameters. MLM accommodates for samples with differing 
group sizes and timing of assessments (Raudenbush & Bryk, 2002).  MLM was used for 
all analyses examining the growth trajectories of the outcome measures (ADHD, ASD, 
and anxiety symptoms) as well as the relationship between effortful control and the 
outcome measures.  
Diagnostic analyses of the data were conducted to examine the key assumptions 
of hierarchical linear modeling.  Plots of residual and error terms examined the 
independence and normality of residuals at Level 1 as well as homoscedasticity of 
variance. The data was examined for influential data points including outliers and none 
were found.  
The CBCL ADHD- and anxiety-raw scores were standardized to make 
interpretation meaningful. Age in years and developmental level were centered at the 
mean for MLM analyses so that the intercept could be interpreted as the predicted level 
of the outcome (ADHD, ASD, and anxiety symptoms) at the mean age/developmental 
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level for the sample, this effectively controls for differences in age and development level 
across participants.  
To assess the primary hypotheses, a series of multilevel unconditional and 
conditional models were built testing the effect of effortful control (level 2 predictor) on 
the initial level and change of ADHD, ASD, and anxiety symptoms (dependent 
variables). Two separate analyses were conducted for each of the dependent variables 
(ADHD, ASD, and anxiety symptoms) examining the independent role of effortful 
control. Before assessing the role of effortful control on the initial level and change in the 
dependent variable, unconditional models were fit to estimate the level and change in the 
dependent variable over time illustrated in the following equation illustrating the within-
subjects effects. 
Level 1 (within–subjects):  Yti = π0i + π1i Ageti + eti 
Level 2 (between-subjects):  π0i = β00 + r0i 
π1i = β10 + r1i  
Yti represents the dependent variable (ADHD, ASD, and anxiety symptoms) for time t 
within individual i. π0i  and π1i represent the intercept and slope, respectively, for 
individual i. eti represents the random error for model. This basic growth model was used 
as a foundation for several models to address the hypotheses.  
To test the hypothesis that children with FXS will exhibit higher levels of ADHD, 
ASD, and anxiety symptoms with relative stability across ages, group membership was 
added as a fixed effect to the growth model while controlling for developmental level. 




Level 1  
(Within-Subjects) 
 Yti = π0i +  π1i Age+  π2i Developmental Level+ π3i Group  + eti  
Level 2  
(Between-Subjects) 
π0i = β00 + r0i 
π1i = β10  + rii 
π2i = β20  
π3i = β30  
To examine whether the level and change in the dependent variable will vary as a 
function of effortful control, this predictor was added to the model as a Level 1 effect. 
The random effects of effortful control was tested to allow for variability with-in 
individuals; however, it was not included in the final model as they were not significant 
and did not increase to the model fit. 
The final models for each outcome (ADHD, ASD, and Anxiety symptoms) 
included the following: 
Level 1 
(Within-Subjects) 
Yti = π0i +  π1i Age+  π2i Developmental Level+ π3i Group  + π4i Effortful  
Control + eti  
Level 2  
(Between-Subjects) 
π0i = β00 + r0i 
π1i = β10  + r1i 
π2i = β20  
π3i = β30  
π4i = β40 
	  
The intercept coefficient (π0i) measures the overall level in the outcome as a 
function of age (π11), developmental level (π2i), group (π3i), and effortful control (π4i). β 
estimates measure the fixed effects while r estimates measure the random effect of age. 
Due to the fact that only the first time point was available for the participants with 
cortisol data, multi-level modeling could not be used. Multiple linear regression models 
were, instead, conducted to assess the relationship between cortisol and the outcome 
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measures (ADHD, ASD, and anxiety symptoms) while controlling for age, 
developmental level, and group membership.  
Diagnostic analyses of the data were conducted to examine the key assumptions 
of linear regression.  Plots of residual and error terms examined the independence and 
normality of residuals as well as homoscedasticity of variance. The data was examined 
for influential data points including outliers and none were found. Due to a skewed 
distribution, cortisol was transformed using a log base 10 transformation.  
To examine the relationship between cortisol levels and ADHD, ASD, and 
anxiety symptoms, three separate multiple linear regression models were built. The final 
model included cortisol predicting the outcome (ADHD, ASD, and anxiety symptoms) 
while controlling for age, developmental level, and group membership, Y=B0+ B 1(Age)+ 
B 2(Developmental Level)+ B 3(Group)+ ßB4(Cortisol)+ ei. Interaction effects of cortisol 
with age and group were tested; however, due to decreased model fit and non-significant 
findings, these interaction effects were not included in the final model.   
Additionally, other variables were tested as confounding factors in the MLM and 
linear regression analyses. Specifically, the form of the Rothbart measure used to 
measure effortful control was tested and did relate to ASD outcome measures. This will 
be discussed as a limitation of the current study.   A dummy coded variable of missing 
cortisol was coded and determined not to be a confounding factor.  
3.2 RESULTS 
ADHD Symptoms 
When examining the hypothesis that the FXS group will exhibit higher levels of 
ADHD symptoms with relative stability across ages, a series of multi-level models were 
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built controlling for developmental level with age and group membership as predictors. 
Results of the basic growth model (see Table 3.3- Model 1) indicated no significant 
differences in mean levels of ADHD symptoms across the sample (β00 =-0.14, p=0.58).  
However, the intercept of the slope is significant (r0i=0.64, p<.0001) indicating 
significant variability in ADHD trajectories. Figure 3.1 illustrates the variability in 
individual trajectories for each group. The fixed effect of age was significant indicating 
that mean levels of ADHD symptoms increase as age increases (β10=0.08, p=0.09). The 
random slope of age (r1i=0.08, p=.80) is not significant. Developmental level had a 
negative effect on ADHD symptoms such that as developmental level increased, ADHD 
symptoms decreased (β20=-0.01, p=0.04). The fixed effect of group membership was not 
significant indicating that mean levels of ADHD symptoms did not differ across the 
groups (β30=0.21, p=0.51). These results suggest no specific trend in ADHD symptoms 
between groups. Figure 3.2 compares the flat trajectories of ADHD symptoms by group. 
To examine the hypotheses of lower levels of effortful control predicting higher levels of 
ADHD symptoms in both groups effortful control was added as a predictor to the basic 
growth model. Effortful control was not found to significantly predict mean levels of 
ADHD symptoms (β40=-0.07, p=0.26; Table 3.3 -Model 2).  
The results (Table 3.4) of the linear regression model examining the relationship 
between cortisol and ADHD symptoms indicated that when controlling for age, 
developmental level, and group membership, cortisol levels did not significantly predict 
ADHD symptoms (B=0.20, p=0.62). Increasing age (B=0.26, p=0.04) did significantly 





To examine the hypothesis that the FXS group will exhibit higher levels of ASD 
symptoms with relative stability across ages, a multi-level model was built controlling for 
developmental level with age and group as predictors (Table 3.5-Model 1). Results of the 
basic growth model indicated that when controlling for developmental level, there were 
significant differences in mean levels of ASD symptoms (β00 =19.76, p=0.0000) across 
the sample. Additionally, significant variability in individual trajectories was found 
(r0i=3.42, p<.0001; See Figure 3.3). While the fixed effect of age was not significant 
(β10=-0.08, p=0.82), the random effect of age reached significance indicating that 
variability in age among individuals predicted variability in ASD trajectories (r1i=2.15, 
p=.002). While developmental level was used a covariate, a significant fixed effect was 
found indicating that lower developmental levels related to increased mean levels of ASD 
symptoms (β20 =-0.13, p=0.001). Similarly, group membership significantly predicted 
differences in ASD symptoms (β30=6.14, p=0.007) indicating that the FXS group 
displayed higher mean levels of ASD symptoms. Figure 3.3 illustrates the variability in 
individual trajectories across ages for each group.  Figure 3.4 displays the mean 
differences and growth trajectories in ASD symptoms across groups. To examine the 
hypotheses of lower levels of effortful control predicting higher levels of ASD symptoms 
in both groups effortful control was added as a predictor to the basic growth model (see 
Table 10). Effortful control was not found to significantly predict mean levels of ASD 
symptoms (β40=-0.64, p=0.09; Table 3.5-Model 2).  
The results (Table 3.6) of the linear regression model examining the relationship 
between cortisol and ASD symptoms indicated that when controlling for age, 
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developmental level, and group membership, cortisol levels did not significantly predict 
ASD symptoms (B=-1.80, p=0.37). Similar to the multi-level modeling results, lower 
levels of developmental level related to higher levels of ASD symptoms (B=-0.22, 
p=0.01).  
Anxiety Symptoms	  
To examine the hypothesis that the FXS group will exhibit higher levels of 
anxiety symptoms with relative stability across ages, a multi-level model was built 
controlling for developmental level with age and group as predictors (Table 3.7- Model 
1). Results of the basic growth model indicated that when controlling for developmental 
level, there were no significant differences in mean levels of anxiety symptoms (β00 =-
0.23, p=0.45) across the sample; however, the random slope of the intercept was 
significant demonstrating variability in anxiety slopes across the sample (r0i=0.74, 
p<.0001; see Figure 3.5).  The fixed effect of age did not reach significance indicating 
that age did not related to mean levels of anxiety symptoms (β00 =-0.03, p=0.62). 
Similarly, the growth rate or the random slope of age was not significant indicating no 
variability in trends in anxiety trajectories across ages (r1i=0.000004, p=.99). Mean levels 
of anxiety symptoms did not differ across groups (β30 =0.30, p=.44). Figure 3.6 illustrates 
the flat trajectories of anxiety symptoms across groups. To examine the hypotheses of 
lower levels of effortful control predicting higher levels of anxiety symptoms in both 
groups effortful control was added as a predictor to the basic growth model (see Table 
3.7- Model 2). Effortful control was not found to significantly predict mean levels of 
anxiety symptoms (β40=-0.04, p=0.62).  
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The results (Table 3.8) of the linear regression model examining the relationship 
between cortisol and anxiety symptoms indicated that when controlling for age, 
developmental level, and group membership, cortisol levels did significantly predict 
anxiety symptoms (B=0.79, p=0.04). More specifically, higher cortisol levels predicted 
higher levels of anxiety.  
Post-hoc Analyses 
Post-hoc exploratory descriptive analyses were conducted to examine the 
comorbidities of elevated symptoms of ADHD, ASD, and anxiety symptoms in the FXS 
participants at one or more time points. Table 3.9 presents these results. Nine participants 
(15%) had elevated ADHD and ASD symptoms, 1 participant (1.66%) had elevated 
ADHD and anxiety symptoms, and 3 participants (5%) had elevated levels of ADHD, 





Table 3.1. Overview of Observation Totals by Predictor Variables 
   Variable 
Group Time Effortful Control (EC) Cortisol 
1 60 25 
2 42 0 FXS 
3 16 0 
 Total 119 25 
1 34 21 
TD 
2 5 0 




Table 3.2. Study 2 Descriptives at First Observation   
 Group 
 FXS   TD 
Variable n M (SD) Range  n M (SD) Range 
Age (years) 60 
4.01  
(1.07) 1.5- 5.76  34 
3.07  










(0.87) -2.05- 2.38  34 
-0.69  










(0.94) -1.16- 3.33  34 
-0.4  




(1.06) -2.74- 2.06  34 
0.6  
(0.79) -0.97- 2.35 
Cortisol 25 
0.33  
(0.34) 0.04- 1.79  21 
0.14  
(0.13) 0.04- 0.52 
        
Developmental Level=Vineland Adaptive Behavior Composite Score  
ADHD/ Anxiety Symptoms= Child Behavior Checklist DSM Standardized Raw 
Scores 
ASD Symptoms= Childhood Autism Rating Scale Total Score  









Model 1    
Model 2 
Variable Estimate SE 
Variance  
Estimate  Estimate SE 
Variance  
Estimate 
Intercept -0.14 0.25 0.64*  -0.11 0.25 0.62* 
Growth Rate  
(Age)  0.14** 0.05 0.08  
0.15* 0.05 0.05 
Developmental  
Level 
-0.01* 0.007   -0.01* 0.007  




  -0.07 0.06  
Level-1 error   0.47    0.49 
  
χ2 model fit 
improvementa=0.06 
 χ2 model fit improvement= 
0.005 
Note:  *p<.05, **p<.01, ***p<.001; aModel fit compared to unconditional model 
Number of observations: 157 
Number of groups: 94 
Developmental Level= Vineland Adaptive Behavior Composite Score 





Table 3.4. Linear Regression Results of Cortisol Predicting ADHD Symptoms 
Note: n= 46 
Developmental Level= Vineland Adaptive Behavior Composite Score 
ADHD Symptoms= Child Behavior Checklist Standardized DSM ADHD Raw Score 
Variable B SE t-value p F df p R2 
Intercept -1.85 1.73 -1.07 0.29 5.41 4, 41 0.001 0.28 
Age (years) 0.26 0.12 2.15 0.04     
Developmental 
Level 





Group 0.82 0.57 1.43 0.16     








Model 1    
Model 2 
Variable Estimate SE 
Variance  
Estimate  Estimate SE 
Variance  
Estimate 
Intercept 19.76*** 1.35 3.42***  19.97*** 1.35 3.45*** 
Growth Rate  
(Age)  -0.08 0.37 2.15**  
0.03 0.37 2.09** 
Developmental  
Level 
-0.13** 0.04   -0.12** 0.04  




  -0.64 0.37  
Level-1 error   1.97    1.95 
  
χ2 model fit 
improvementa=9.89** 
 χ2 model fit improvement= 
8.90** 
Note:  *p<.05, **p<.01, ***p<.001; aModel fit compared to unconditional model 
Number of observations: 157 
Number of groups: 94 
Developmental Level= Vineland Adaptive Behavior Composite Score 




Table 3.6. Linear Regression Results of Cortisol Predicting ASD Symptoms 
Note: n= 39 
Developmental Level= Vineland Adaptive Behavior Composite Score 
ASD Symptoms= Childhood Autism Rating Scale Total Score 
 
Variable B SE t-value p F df p R2 
Intercept 39.93 8.85 4.52 .00001 15.9  4, 34 .000000 0.61 
Age (years) -1.01 0.61 -1.64 0.11     
Developmental  
Level 





Group 2.53 3.09 0.82 0.42     








Model 1    
Model 2 
Variable Estimate SE 
Variance  
Estimate  Estimate SE 
Variance  
Estimate 
Intercept -0.23 0.30 0.74***  -0.22 0.31 0.73*** 
Growth Rate  
(Age)  0.03 0.06 .000004  




-0.002 0.009   -0.001 0.009 
 




  -0.04 0.08  
Level-1 error   0.62    0.63 
  
χ2 model fit 
improvementa=.00000 
 χ2 model fit improvement= 
.00000 
Note:  *p<.05, **p<.01, ***p<.001; aModel fit compared to unconditional model 
Number of observations: 157 
Number of groups: 94 
Developmental Level= Vineland Adaptive Behavior Composite Score 




Table 3.8. Linear Regression Results of Cortisol Predicting Anxiety Symptoms 
Note: n= 39 
Developmental Level= Vineland Adaptive Behavior Composite Score 
Anxiety Symptoms= Child Behavior Checklist Standardized DSM Anxiety Raw Score 
Variable B SE t-value p F df p R2 
Intercept -0.46 1.65 -0.28 0.78 1.36 4, 41 0.26 0.03 
Age (years) 0.04 0.11 0.33 0.74     
Developmental  
Level 
0.01 0.01 0.44 0.66     
Group 0.15 0.55 0.27 0.79     
Cortisol 0.79 0.38 2.01 0.04     
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Table 3.9. Descriptives of Group Comorbidities 




Groups n %` M (SD) M (SD) M (SD) 
FXS + ADHD + 
ASD 
9 15% 4.31 (0.6) 53.11 (10.2) -0.38 (1.03) 
FXS + ADHD + 
Anxiety 
1 1.66% 5.65 56 -0.73 
FXS + ASD + 
Anxiety 
0 0.00%    
FXS + ADHD + 
ASD + Anxiety 
3 5% 3.45 
(1.02) 
54.67 (6.81) -0.14 (0.81) 

























Figure 3.2. Comparison of FXS and TD growth trajectories of ADHD symptoms from 





















    
























Figure 3.6. Comparison of FXS and TD growth trajectories of anxiety symptoms from 












Attention-Deficit Hyperactivity Disorder, ASD, and anxiety are three of the most 
common mental health disorders in children with higher rates in children with FXS. To 
facilitate early intervention and treatment efforts across children with FXS and typically 
developing populations, early identification and a better understanding of the precursors 
and mechanisms of these disorders is necessary. The neuroconstructivist approach is an 
ideal theory because this approach recognizes the bi-directional role of genetics, 
cognition, physiology, and behavior interacting over time (Cornish et al., 2004).  The 
current studies investigated the relationship between impaired effortful control 
(precursor) and HPA axis dysfunction (underlying mechanism) and their individual 
impacts on the emergence and stability of ADHD, ASD, and anxiety symptoms in boys 
with FXS compared to typically developing boys.  
Study 1  
Consistent with previous literature, the current studies revealed lower levels of 
effortful control and higher levels of cortisol in boys with FXS compared to boys of 
typical development (Robinson et al., in preparation; Wisbeck et al. 2000; Hessl et al., 
2002; Hessl, Glaser, Dyer-Friedman, & Reiss, 2006; Hessl, Rivera, & Reiss, 2004). 
While effortful control and cortisol have theoretical and empirical links in young children 
(Watamura et al., 2004; Dettling et al., 2000), the current studies do not support this 
relationship in children with FXS.   Previous research has shown that a negative 
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relationship between cortisol levels and parent reported effortful control in typically 
developing children ages 12 to 36 months with the strongest relationships in children 
ages 24 months of age (Watamura et al., 2004). Similarly, in a sample of typically 
developing children ages 3 to 5 years, lower levels of effortful control were related to 
increased levels of cortisol (Dettling et al., 2000). While the current sample included 
young children of similar ages, no previous studies have examined the relationship 
between cortisol and effortful control in clinical samples. Previous findings in typically 
developing samples and the null finding in FXS may suggest that the link between 
effortful control and cortisol requires typical brain development that is not seen in 
children with FXS. However, this is the first study to examine this relationship and future 
research is needed to replicate these results and to understand why effortful control and 
cortisol may not be related in children with FXS.   
Study 2 
ADHD, ASD, Anxiety Symptoms in FXS. We hypothesized that children with 
FXS would exhibit higher levels of ADHD, ASD, and anxiety symptoms. Group 
membership did predict increased levels of ASD symptoms as the FXS displayed higher 
mean levels of ASD across all ages. We did not find this same effect with ADHD and 
anxiety symptoms. While the current studies focused on symptom severity rather than 
diagnostic classification to better address the emergence of symptoms, over 32% of the 
FXS participants had clinically significant ASD symptoms, 22.5% had clinically 
significant ADHD symptoms, and only 8.75% of the FXS displayed clinically significant 
anxiety symptoms. Therefore, ASD symptoms were most prevalent in our study and 
consistent with reported prevalence rates of 29% based on CARS total scores in a broader 
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age range of boys with FXS (e.g. 18 months to 14 years; Hatton et al., 2006). See Figure 
4.1. Our findings support the early emergence of ASD symptoms in young children with 
FXS.  
The prevalence rates of ADHD and anxiety disorders in our sample are much 
lower than reported rates 41- 93% meeting criteria for ADHD (Sullivan et al., 2006) and 
86% of males with FXS meeting criteria for anxiety disorders (Cordeiro et al., 2011).  
Most previous studies examining prevalence rates of ADHD and anxiety symptoms 
within FXS included children and adults ages 5 and up; therefore, our study is one of the 
first to examine these behavioral symptoms in young children with FXS. While our 
prevalence rates of ADHD and anxiety are far below expectations for children with FXS, 
our rates exceed prevalence rates of these disorders in preschool-aged children within the 
general population (see Figure 4.2). For example, a meta-analysis of ADHD diagnoses 
revealed an average prevalence rate of 10.5% in children ages 3 to 5 years old (Willcutt, 
2012), and rates of anxiety disorders in preschoolers have been reported to range from 6.1 
to 9.5% (Costello, Egger, and Angold, 2005).  
In addition, the increased prevalence rate of ASD symptoms compared to ADHD 
and anxiety symptoms is consistent with the average age of diagnosis as ASD can be 
reliability diagnosed at 2 to 3 years old with symptoms often appearing as early as 12 
months of age (Ozonoff et al., 2010) while ADHD is typically diagnosed between the 
ages of 5 and 7 in the general population (CDC, 2010) and anxiety in middle childhood 
before the age of 12 (Beesbo, Knappe, & Pine, 2009). Our studies used young children 
ages 18 months to 6 years, which falls most in line with the emergence and identification 
of ASD.  While statistically significant group differences in ADHD and anxiety 
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symptoms were not found, elevated symptoms were reported and exceed general 
population prevalence rates during the preschool years highlighting the vulnerability of 
these young children with FXS.   
Developmental trajectories.  A major focus of this longitudinal study was to 
examine the developmental trajectories of ADHD, ASD, and anxiety symptoms in boys 
with FXS compared to typically developing children. The current studies indicate 
significant variability in ADHD, ASD, and anxiety trajectories across FXS and typically 
developing young boys. More specifically, we did not find specific developmental 
trajectories for the FXS group due to the variability of symptoms profiles among 
individuals as some showed increases while others decreased and some remain stable 
across time. While we hypothesized changes over time in the FXS group, the lack of this 
finding is consistent with the heterogeneity of the FXS phenotype. Developmental 
changes may be more apparent when examining the trajectories of symptom severity in 
more homogeneous groups of children with FXS (i.e. similar developmental levels, 
diagnosed ADHD +FXS, etc.). Additionally, developmental changes may been seen later 
in childhood and early adolescence as our study focused on the emergence of these 
symptom profiles in young children. Due to developmental and cognitive delays in 
children with FXS, developmental changes may occur later than the typical population, 
which may be evident when examining a broader age range.  
Effortful control. Despite significantly lower levels of effortful control in boys 
with FXS compared to boys of typical development, effortful control was not found to 
significantly predict ADHD, ASD, or anxiety symptoms. The relationships of impaired 
effortful control with ADHD and ASD symptoms have been shown in previous studies of 
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young children without FXS of similar ages to our sample (Murray & Kochanska, 2002; 
Kochanstantareas & Strewart, 2003); however, no studies have examined the link 
between effortful control and anxiety in children under the age of 5 indicating that the 
link between effortful control and anxiety symptoms is unknown. Our null finding 
linking effortful control with ADHD and ASD symptoms in children with FXS was not 
expected due to the significant impairments in effortful control that exist in FXS. 
However, the fact that effortful control and these behavioral symptoms are not related is 
important, as this is the first study to examine these relationships in FXS. FXS is a 
multifaceted genetic disorder that causes changes in brain development (Cornish et al., 
2004); therefore, the lack of the relationship between effortful control and these 
behavioral outcomes within FXS is still important to our understanding of the FXS 
phenotype.  
Cortisol. Increased cortisol was found to predict increased anxiety symptoms. 
Due to the low prevalence rate of elevated anxiety symptoms in our current FXS sample 
compared to previously reported prevalence rates, the relationship between cortisol and 
anxiety in the current study was unexpected. The elevated cortisol levels in the FXS 
group that link to anxiety symptoms shows the robust role of physiological mechanisms 
such that HPA axis dysfunction is evident before behavioral symptoms of anxiety. These 
findings may facilitate earlier identification and treatment of anxiety in children within 
FXS as physiological dysregulation may serve as a precursor to anxiety symptoms and 
disorders.   
Cortisol was not found to significantly relate to ADHD or ASD symptoms in the 
current study. Previous research in ADHD and ASD groups report decreased cortisol 
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levels in the clinical groups compared to typically developing children (Ma, Chen, Chen, 
Liu, & Wang, 2011; Ćurin, Terzić, Petković, et. al, 2003). Conversely, FXS literature 
suggests overall increased cortisol levels compared to typically developing children 
(Wisbeck et al. 2000; Hessl et al., 2002; Hessl, Glaser, Dyer-Friedman, & Reiss, 2006; 
Hessl, Rivera, & Reiss, 2004), which is more similar to clinical groups with anxiety 
disorders (Costello et al., 2001). Reduced levels of cortisol have been found to relate to 
ASD symptoms in adolescent boys with FXS (Hall, Lightbody, & Reiss, 2008), but there 
are mixed findings in the relationship between cortisol levels and ADHD symptoms in 
boys with FXS (ages 6-17) as one study found a positive relationship between cortisol 
and ADHD symptoms while another did not find a significant relationship between the 
two factors (Hessl et al., 2002; Hessl et al., 2002). Therefore, the lack of the relationship 
between ADHD and ASD symptoms may be due to the fact that our FXS group showed 
increased levels of cortisol instead of decreased levels that are shown in other clinical 
groups to relate to ADHD and ASD symptoms. Additionally, previous studies examining 
cortisol and behavior outcomes included older age groups than used in the current study 
indicating that our participants may not be showing clinically significant symptoms at 
young ages.  
Limitations 
Several limitations need to be noted regarding the current studies. First, the 
participants included in these studies were drawn from three related and sequential yet 
independent studies on the early development of FXS. Due to the low incidence rates of 
FXS, it was important to utilize subjects from all studies; however, two site locations 
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were included (UNC and USC) and procedures differed slightly, which may result in site 
effects that could confound some results.  
Second, our FXS and typically developing participants were not matched on 
developmental age. However, a measure of adaptive skills was included and used as a 
covariate in our analyses to control for differences in developmental level. This proxy 
measure of developmental level was found to strongly correlate with a direct assessment 
of developmental or early cognitive skills further supporting its use. While our parent 
reported measure was found to be reliable measure of developmental level, it did not 
provide an estimate of mental age. Throughout all analyses, the measure of 
developmental level was found to relate to effortful control, ADHD symptoms, and ASD 
symptoms. Significant group differences in developmental level were expected and found 
between the FXS and TD groups.  More specifically, the FXS group displayed 
significantly lower developmental levels compared to the TD group. Due to the 
correlation between developmental level and group membership, the use of 
developmental level as a covariate may have accounted for group differences. Similarly, 
the effect of effortful control on ADHD, ASD, or anxiety symptoms may have been 
overshadowed by the effects of developmental level. The use of developmental level as a 
covariate was necessary to account for developmental delays in the FXS; however, it is 
not known if additional effects would have been found if developmental level was 
accounted for in other ways, such as mental age matching.  
Third, due to age related changes in cognitive and temperament development, two 
versions of the Rothbart temperament scales were utilized to take into account age related 
changes. Two scales based on age (18-36 months, 3-7 years) were included in the 
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analyses together so that we could examine the behavioral outcomes across ages. If we 
used only the childhood scale (ages 3-7) we would not have been able to examine the 
emergence of these behaviors and if we did not include the childhood scale, we would 
have lost the longitudinal nature of the study. While strong reliability exists for the use of 
these scales, the use of two scales may pose a measurement issue.  
Future Directions 
Due to the greater negative outcomes associated with co-occurring conditions 
within FXS including severe social, academic, and adaptive behavior difficulties (Pearson 
et al., 2003; Bailey et al., 2008), early identification and treatment is essential. The 
current studies are one of the first to examine comorbidities within FXS and also one of 
the first to examine the emergence of these comorbidities by examining behavioral 
outcomes in young children with FXS. Examining the emergence of these disorders 
highlights the need for a better understanding of the trajectories of these disorders to 
better facilitate the timing and specificity of treatment efforts. For example, due to the 
link between impaired physiological functioning and anxiety, treatment efforts to reduce 
or prevent the development of anxiety symptoms may focus on stress reduction efforts. 
Future research may include examining the trajectories of ADHD, ASD, and anxiety 
symptoms throughout middle childhood and adolescence to see if developmental profiles 
emerge or if individual variability continues. The individual variability in the growth 
trajectories of ADHD, ASD, and anxiety across boys with FXS supports the need for 
individualized treatment plans of all children with FXS.  
The current studies utilized parent rating scales and observer ratings of ADHD, 
ASD, and anxiety symptoms. While these procedures are supported in the literature and 
	  
71	  
are highly predictive of diagnostic classification, future research should include direct 
assessment and diagnostic procedures of ADHD, ASD, and anxiety. More specifically, 
our prevalence rates of ASD symptoms is consistent with previous research using the 
CARS; however, increased prevalence rates as high as 60-75% of males with FXS have 
been shown using direct assessment of ASD specific symptoms such as the Autism 
Diagnostic Observation Schedule (Clifford et al., 2007; Hall, Burns, Lightbody, & Reiss, 
2008; Harris et al., 2008). No studies to date have used diagnostic measures of ADHD 
symptoms in children with FXS as all studies to date have used informant rating scales. 
Therefore, the true prevalence rates of ADHD within FXS are not yet known. Future 
research may examine the emergence of ADHD, ASD, and anxiety symptoms using 
direct assessment to make diagnostic decisions, which may provide more sensitivity in 
identifying clinically significant symptoms at early ages.  However, the rating scales and 
observer ratings are still important as they highlight symptom severity, inform treatment 
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